-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EVO-756 in Chronic Urticaria Or Hives
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EVO-756 in Chronic Urticaria Or Hives report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EVO-756 in Chronic Urticaria Or Hives Drug Details: EVO-756 is...
-
Product Insights
Aortic and Vascular Graft Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Aortic and Vascular Graft Devices Pipeline Market Report Overview Aortic Stent and Vascular Graft Devices include Aortic Stent Grafts and Vascular Grafts. The Aortic and Vascular Graft Devices pipeline market research report provides comprehensive information about the Aortic and Vascular Graft devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Segments ·       Vascular Grafts ·       Abdominal Aortic Stent Grafts ·       Aortic Stent Grafts...
-
Product Insights
X2 Dev – Vake Park Side Residence – T’bilisi
Equip yourself with the essential tools needed to make informed and profitable decisions with our X2 Dev - Vake Park Side Residence - T'bilisi report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
X2 Dev – Kazbegi Residence Multifunctional Residential Complex – T’bilisi
Equip yourself with the essential tools needed to make informed and profitable decisions with our X2 Dev - Kazbegi Residence Multifunctional Residential Complex - T'bilisi report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
X2 Dev – Tsereteli Deluxe Multifunctional Residential Tower – T’bilisi
Equip yourself with the essential tools needed to make informed and profitable decisions with our X2 Dev - Tsereteli Deluxe Multifunctional Residential Tower - T'bilisi report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Company Profile
NewTandem Diabetes Care Inc – Company Profile
Tandem Diabetes Care Inc (Tandem) is a medical device manufacturing company that designs and develops diabetic care products. The company's product portfolio includes X2 insulin pump, basal-IQ technology, Control-IQ technology, software and applications, infusion sets and other pump accessories. In addition, it also offers connected health offerings. Tandem also provides product support services helping its clients to further customize their systems. The company distributes its products across various regions including Canada, Australia, New Zealand, Saudi Arabia and South Africa. Tandem...
Add to Basket -
Product Insights
Tandem Diabetes Care Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Tandem Diabetes Care Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Tandem Diabetes Care Inc (Tandem) is a medical device manufacturing company that designs and develops diabetic care products. The company's product portfolio includes t:slim X2 insulin pump, basal-IQ technology, Control-IQ technology, software and applications, infusion sets and other pump accessories. In addition, it also offers connected health offerings. Tandem also provides product support services helping its clients to...
-
Product Insights
Vascular Grafts Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Vascular Grafts Pipeline Products Market Report Overview Vascular grafts are tubes made up of natural tissue or synthetic materials surgically implanted in the veins and arteries. These are the implants used to repair, bypass, or replace sections of blood vessels during surgical procedures. They are also used to patch injured or diseased areas in the arteries and for the replacement of whole segments of larger arteries such as the aorta. The vascular grafts pipeline market research report provides comprehensive information...
-
Product Insights
Peripheral Vascular Stents Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Peripheral Vascular Stents Pipeline Products Market Report Overview A peripheral vascular stent is an expandable perforated tube that is inserted into a peripheral vessel to prevent blood flow constriction. The Peripheral Vascular Stents pipeline market research report provides comprehensive information about the Peripheral Vascular Stents pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Product Insights
Cells Expressing Melanoma Associated Antigen 4 (Cancer-Testis Antigen 1.4 or MAGE 4 Antigen or MAGE 41 Antigen or MAGE X2 Antigen or MAGEA4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Cells Expressing Melanoma Associated Antigen 4 (Cancer/Testis Antigen 1.4 or MAGE 4 Antigen or MAGE 41 Antigen or MAGE X2 Antigen or MAGEA4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players report provides in depth analysis on Cells Expressing Melanoma Associated Antigen 4 (Cancer/Testis Antigen 1.4 or MAGE 4 Antigen or MAGE 41 Antigen or MAGE X2 Antigen or MAGEA4) targeted pipeline therapeutics. The report provides comprehensive information complete with Analysis by...